The emerging phenomenon of vaping 5MeO dimethyltryptamine in the nation presents considerable hazards and complex juridical issues. Currently, 5MeO dimethyltryptamine remains a Schedule I substance according to Canadian Controlled Drugs and Substances Act, making its possession and supply unlawful. While ingestion delivers the compound swiftly, it